siRNA, Anti-MAP1LC3C, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT66207WQ-2OMe)

The product SIRGT66207WQ-2OMe is a type of small interfering RNA (siRNA) that targets MAP1LC3C gene and regulates the expression of gene. The siRNA interferes with the expression of MAP1LC3C gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001004343.2
Alternative Names ATG8J; LC3C
Related Diseases Hyperoxaluria, Primary, Type Ii
Purification HPLC
Target Gene
Gene ID 440738
Uniprot ID Q9BXW4
Sub Cat Target Species Modification Scale  
SIRGT67207WQ-2F MAP1LC3C Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT68207WQ-2MOE MAP1LC3C Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT66207WQ-RB MAP1LC3C Human Ribo-modified Inquiry
SIRGT67207WQ-BB MAP1LC3C Human Backbone-modified Inquiry

Related Products